International Journal of Clinical Pharmacy 2013-08-01

Thrombocytopenia associated with 5-aminosalicylate prodrug, olsalazine: is the devil still there?

Yuefeng Rao, Feiyue Zheng

Index: Int. J. Clin. Pharm. 35(4) , 529-31, (2013)

Full Text: HTML

Abstract

We present a case of a 63-year-old Chinese female who developed severe thrombocytopenia after receiving olsalazine 1.5 g daily for 3 months, and eventually culminated in hospital admission. According to a Medline search, this is the first case report of olsalazine-associated thrombocytopenia in Asia.Olsalazine, similar to other 5-aminosalicylates, can also cause thrombocytopenia. Clinicians should be aware of this potential adverse drug reaction. Future studies should focus on the trigger mechanism and possible cross-reaction between olsalazine and other aminosalicylates.

Related Compounds

  • Olsalazine (Disod...

Related Articles:

Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.

2006-04-01

[Rev. Gastroenterol. Disord. 6(2) , 97-105, (2006)]

Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.

2013-04-09

[Life Sci. 92(12) , 708-18, (2013)]

Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.

2002-04-01

[J. Vet. Pharmacol. Ther. 25(2) , 135-43, (2002)]

Different therapy for different types of ulcerative colitis in China.

2004-05-15

[World J. Gastroenterol. 10(10) , 1513-20, (2004)]

High thiopurine metabolite concentrations associated with lymphopenia in inflammatory bowel disease (IBD) pediatric patients receiving aminosalicylates combined with azathioprine.

2010-04-01

[Int. J. Clin. Pharmacol. Ther. 48(4) , 275-81, (2010)]

More Articles...